Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
Indian J Pediatr
; 2008 Mar; 75(3): 229-33
Article
en En
| IMSEAR
| ID: sea-78680
ABSTRACT
OBJECTIVE:
To assess the responses to ATG and cyclosporin combination in patients of aplastic anemia.METHODS:
Twenty three (17M 6F) patients of aplastic anemia (11 very severe aplastic anemia (VSAA) and 12 severe aplastic anemia (SAA), were administered antithymocyte globulin and cyclosporin.RESULTS:
The median age of patents was 8 years (range 6-12 years). Three patients died within 2 months of therapy. Twenty children (11 SAA and 9 VSAA) were finally analysed. Six months after the start of treatment, 8/20 (40%) patients responded-2 complete (CR) and 6 partial responses (PR). At the end of 1 year; 2 patients maintained CR and seven patients continued PR (overall responders 45%). The response was better in SAA (54.5%) with 2 CR and 4 PR; than in VSAA (33%) with 3 PR . Eleven (55%) children were alive without response. One patient developed AML 13 months later.CONCLUSION:
We conclude that antithymocyte globulin and cyclosporin combination is an effective treatment for aplastic anemia patients who are ineligible for bone marrow transplantation.
Texto completo:
1
Índice:
IMSEAR
Asunto principal:
Recurrencia
/
Femenino
/
Humanos
/
Masculino
/
Niño
/
Resultado del Tratamiento
/
Ciclosporina
/
Inmunosupresores
/
Anemia Aplásica
/
Suero Antilinfocítico
Idioma:
En
Revista:
Indian J Pediatr
Año:
2008
Tipo del documento:
Article